Eric T Romeo

Eric Romeo is an associate in Goodwin's IP Litigation Group, with a focus on pharmaceutical patent litigation for both innovator and generic clients.  Eric has also represented clients in the chemical, biological, and technology industries, and specializes in working with expert and technical witnesses. Beyond litigation, Eric's experience includes patent prosecution, IPR proceedings, and freedom to operate analysis. Eric also devotes significant time to representing pro bono clients in criminal and immigration matters.

Prior to joining Goodwin,  Eric worked as a medicinal chemist at Merck Research Laboratories where he designed and synthesized drug compounds to treat cancer, Alzheimer's disease, asthma, inflammation, and schizophrenia.  Among the compounds Eric synthesized at Merck is MK-8351, a novel asthma drug that progressed into human trials.  Eric is an inventor on eight U.S. Patents, including U.S. Patent No. 8,796,310, on which he is the first named inventor.